Novel Agent Perifosine enhances antitumor activity of Bortezomib and rituximab in Waldenstrom Macroglobulinemia
Leleu X, Moreau AS, Jia X, O'Sullivan, Ngo N, Hatjiharissi E, Runnels J, Treon S, Hideshima T, Anderson KC, Ghobrial IM. Novel Agent Perifosine enhances antitumor activity of Bortezomib and rituximab in Waldenstrom Macroglobulinemia. ASH. 2006.